Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
bids .10 higher than Friday closing price
Nice size bids moving up..spread getting tight
Yup! Bids already at $1.36 as people eager to get in!
huge news last week on the closing of this acquisition
https://www.otcmarkets.com/stock/MNNDF/news/Nurosene-Health-Completes-Acquisition-of-Pharma-AI-Leader-Netramark?id=326628
seems like MNNDF is now available on TDA - that will be huge for us that were able to get in early!
Excited to see how this trades this week..social media chatter picking up
Even more than that it keeps showing the company is keeping promises going forward
Looking to see a nice uptick in volume here now..been seeing some nice volume on the CSE under $MEND.CN
NEWS ! I just checked and MNNDF is now on TD Ameritrade!!
Let’s see if TDA picks up MNNDF this week as that would be a huge boost to the PPS
$MNNDF $MEND.CN mental health is coming to the forefront..and this company looks to be a big player..
Check out the website for a better look into this great company..
In suffered a concussion I believe years back that I’m still feeling effects from..I really hope $MNNDF can make great strides in a healthy brain..
Must ready for all potential investors, tons of great info in the investor presentation https://cdn.sanity.io/files/18g0k2jo/production/6447b0967d9b200435dc3e248f31fb51ab76b510.pdf
I highly recommend downloading the Nuro App:
https://nurosene.com/app
Through the app, you’ll learn the value of brain health and how it supports physical health. Our brains learn by doing, so give it the time and tools it needs.
$MNNDF $MEND.CN
$MNNDF looks to start following its CSE $MEND.CN As it closed strong yesterday with good volume..was just recently testing $1.50..these prices are a steal here..
Canadian side continues to be accumulated - once more people are able to buy on the US side it should follow
$MNNDF $MEND.CN acquisition flying under the radar - just wait until more people notice this
https://www.otcmarkets.com/stock/MNNDF/news/Nurosene-Health-Completes-Acquisition-of-Pharma-AI-Leader-Netramark?id=326628
Think so too..as more brokers cover $MNNDF..more traders will have opportunity to get shares here..still new to the OTC
+8% green day on the Canadian side $MEND.CN, should translate here soon me thinks
1.22 was starting support so that makes this a entry point and backtest
They keep adding and building their team with quality people and a lot of mixed talent. This is a good under the radar sleeper in my opinion. One day this is very likely to just pop off I think.
big early volume on the ask on the CSE side
20K hit $1.55
Things are picking up..someone got lucky with a cheap fill today…
more accumulation on the Canadian side today - 82K served and more interest on the US side then usual
Thank you for the share I’m checking that out!
This..is why I love $MNNDF so much..check this out!
$MNNDF $MEND.CN Excellent video shows exactly why this should be part of your portfolio..love watching the story unfold here…https://t.co/gbozaTbPv5
— Tommy Boy Trader (@QuabbinR) October 26, 2021
looks great, exciting potential here!
Great video! Sums up the company and what they are building..
Good morning, check this out from Twitter it’s another video clip from this presentation https://cdn.sanity.io/files/18g0k2jo/production/6447b0967d9b200435dc3e248f31fb51ab76b510.pdf
Here is the post with the video:
$MEND.CN and Otc: $MNNDF Corporate Presentation condensed into a video. https://t.co/WQJ1lNrWZy 👈 is the original, check it out! $LEAS $CYDY $MJLB $HPNN $BMIX $ENZC $STHC $PUGE $HCMC $SPQS $FAMI $MSMY $AVXL $HRAL $HBRM $NTRR $APYP $IFXY https://t.co/1jBldS4vsP pic.twitter.com/fpa02Dx1Qs
— Flippin (@McPennies_) October 26, 2021
Huge addition to the team..this company is going to be bigger then most realize in my opinion..
Olympian Michael Phelps joins Nurosene Mental Health Advisory Council
“It's OK not to be OK.”
$MEND.CN CSE $MNNDF OTC Company new to trading in U.S. but not new to some of some top faces we know..
— Tommy Boy Trader (@QuabbinR) October 25, 2021
Olympian Michael Phelps joins Nurosene Mental Health Advisory Council
“It's OK not to be OK.” pic.twitter.com/pER876QrS3
Can't believe this is still so under the radar. Won't be this quiet for long.
I’m gonna have to try the “train your brain” app because mines getting unruly. :o
$MNNDF great dip opportunity here..it won’t last
Nurosene was founded in 2019 by Daniel Gallucci, a functional neurologist and researcher whose treatments focus on the brain and body.
So much info in that investors pack, even Michael Phelps is involved with MNNDF !
My #1 long term hold..and it’s not even close
$MNNDF make sure to download the app here
https://nurosene.com/app
$MEND.CN
Agreed, just a matter of time before this one gets more eyes and starts to move
Just saw that on twitter..this company is acting more and more like a Nasdaq stock
$MNNDF $MEND updated investor presentation, terrific info in here
https://cdn.sanity.io/files/18g0k2jo/production/6447b0967d9b200435dc3e248f31fb51ab76b510.pdf
I’m expecting some sort of PR again this week as they are very actively pushing to be better
$MNNDF just a little more buying pressure and $1.5 test will get interesting..
These guys are hitting the ground running for the US market!
Huge news Thats flying under the radar
$MNNDF Nurosene Health Completes Acquisition of Pharma AI Leader Netramark
Press Release | 10/21/2021
Nurosene Health Completes Acquisition of Pharma AI Leader Netramark
Canada NewsWire
TORONTO, Oct. 21, 2021
NetraMark's purpose-built AI engine will power Nurosene to collectively design the future of healthcare
TORONTO, Oct. 21, 2021 /CNW/ - Nurosene Health Inc. ("Nurosene" or the "Company") (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF), a healthtech company focused on building a generation of better brains, is pleased to announce that further to its press release dated October 12, 2021, the Company has completed its acquisition ("Acquisition") of NetraMark Corp. ??("NetraMark"). NetraMark, a pharmatech leader, utilizing proprietary AI to optimize and take an IP ownership stake in the path to new drug development, accelerate clinical trials and redefine the landscape of how disorders are treated. Accordingly, NetraMark is now a wholly-owned subsidiary of Nurosene.
Logo (CNW Group/Nurosene Health Inc.)
Summary of the Acquisition
Nurosene acquired all of the issued and outstanding securities of NetraMark for a purchase price of CAD$15,000,000 payable as follows to shareholders of NetraMark: ?(i) ?6,148,325? common shares at a price of approximately $2.09 ("Purchase Shares"), representing an amount of CAD$12,850,000 of the Company and (ii) CAD$2,150,000 in cash. The Purchase Shares are subject to a contractual escrow ranging from 12 to 36 months.
Finder's fees were paid in connection with the Acquisition to arm's length finder that consisted of an aggregate of 215,311 common shares in the capital of the Company (the "Finder Shares"). The Finder Shares are subject to a four (4) month and one (1) day hold period from the date of issuance.
About NetraMark
NetraMark Corp., a specialized AI and pharma-tech company, lead by Dr Joseph Geraci has developed novel solutions utilized by global pharmaceutical and biotechnology companies. These solutions allow them to leverage small to large data sets in order to optimize clinical trials and rapid drug development. This is accomplished by providing a superior understanding of their patient populations with these insights being used to develop new drugs and precision nutraceuticals. By putting a deeper understanding of patients first, NetraMark is in a position to significantly de-risk drug development.
Founded in 2016 by Dr. Joseph Geraci, PhD, and Richard M. Brooks, LLB, NetraMark was built to address current gaps in the pharmaceutical market. Utilizing a new paradigm of unsupervised machine learning, NetraMark provides powerful insights into how to treat patients at the individual level, instead of a 'one size fits all' model. NetraMark was built to accelerate the path towards new medications and nutraceuticals through leveraging their AI and pharma expertise.
About Nurosene
Nurosene provides individuals with tools and technology that empower them to take control of their mental wellness. Our mission is to build the next generation of better, healthier brains by leveraging technological advancements in AI. With our team of experts and partners, Nurosene is positioned at the leading edge of critical research and innovations, striving to disrupt traditional mental wellness treatments.
For more information, visit www.nurosene.com.
Forward-Looking Statements
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which is based upon Nurosene's current internal expectations, estimates, projections, assumptions and beliefs, and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements of fact. Specifically, this news release contains forward looking statements relating to, among others, activities of the Company's acquisition of NetraMark, growth and other initiatives thereto.
Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, Nurosene does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Nurosene to predict all such factors. When considering these forward-looking statements, readers should keep in mind the risk factors and other cautionary statements in Nurosene Final Long Form Prospectus dated May 20, 2021 and filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in Nurosene Final Long Form Prospectus could cause actual events or results to differ materially from those described in any forward-looking information.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
SOURCE Nurosene Health Inc.
Followers
|
10
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1006
|
Created
|
09/22/21
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |